SEC Form 4 · accession 0001209191-18-044260
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathryn A. Torres
Officer — SVP-Payer Contracting & Align.
Period of report
Jul 25, 2018
Accepted (ET)
Jul 27, 2018 · 5:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 25, 2018 | M | 4,250 | $47.97 | A | 9,307 | D | |
| Common Stock | Jul 25, 2018 | F | 2,720 | $118.13 | D | 6,587 | D | |
| Common Stock | Jul 27, 2018 | S | 1,530 | $124.47 | D | 5,057 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF2 | $47.97 | Jul 25, 2018 | M | 4,250 | D | — | Feb 5, 2024 | Common Stock | 4,250 | 0 | D |
Explanation of responses
- F1The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.